Related Experiment Video
Updated: Jul 3, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells
George Kolios1, Vassilis Valatas, Pinelopi Manousou
1Department of Gastroenterology, University of Crete, Greece. gkolios@med.uoc.gr
Abstract:
Nitric oxide (NO) and Monocyte Chemoattractant Protein (MCP)-1 co-regulation has been found in endotoxin-activated macrophages. Kupffer cells (KC) are a main source of soluble-mediators production in liver abnormalities. We investigated in vitro similar co-regulation of NO and MCP-1 production in rat activated KC. Isolated rat KC were cultured in the presence of 1 microg/ml LPS and various concentrations of Wortmannin (0-300 nM), L-NAME (0-500 microM) or MCP-1 (0-100 ng/ml). Production of MCP-1 and NO were measured in supernatants, by ELISA and a modification of the Griess reaction, respectively. Growth arrested KC, stimulated with vehicle, produced a basal amount of NO and MCP-1. In the presence of LPS, cultured KC secreted significantly (P < 0.01) increased amounts of MCP-1 and NO. Pre-treatment of KC with various concentrations of L-NAME significantly (P < 0.05) reduced the LPS-induced secretion of NO in a concentration dependent manner, but the MCP-1 production remained unaffected. Pre-treatment with Wortmannin significantly (P < 0.05) inhibited LPS-induced secretion of MCP-1 and NO in a concentration dependent manner. Linear regression analysis revealed a positive correlation between MCP-1 and NO in the LPS (r = 0.59171, P < 0.0001) and Wortmannin (r = 0.9215, P = 0.009) treated groups, but not in the L-NAME (r = -0.08513, P = 0.873). Incubation of KC with various concentrations of MCP-1 did not increase the NO production. These results indicate that KC might be the main source of NO and MCP-1 production in liver disorders, probably through the induction of PI3-kinase(s) and without any co-regulation between these molecules, which might represent two independent immunoregulatory pathways in the role of KC in hepatic disorders.
Insights
Kupffer cells produce nitric oxide (NO) and Monocyte Chemoattractant Protein-1 (MCP-1) in liver disorders. These molecules are likely independent immunoregulatory pathways, not co-regulated, suggesting distinct roles in hepatic disease.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Macrophages, specifically Kupffer cells (KC) in the liver, are key producers of soluble mediators.
- Previous studies indicated co-regulation of nitric oxide (NO) and Monocyte Chemoattractant Protein-1 (MCP-1) in activated macrophages.
- Understanding KC mediator production is crucial for liver disorder pathogenesis.
Purpose of the Study:
- To investigate the in vitro co-regulation of NO and MCP-1 production in activated rat Kupffer cells.
- To determine the role of PI3-kinase and NO synthase pathways in KC mediator release.
- To elucidate the relationship between NO and MCP-1 production by KC in response to lipopolysaccharide (LPS).
Main Methods:
- Primary rat Kupffer cells were cultured and stimulated with LPS.
- Cells were pre-treated with inhibitors of NO synthesis (L-NAME) and PI3-kinase (Wortmannin), or with MCP-1.
- NO and MCP-1 levels in culture supernatants were quantified using Griess reaction and ELISA, respectively.
Main Results:
- LPS significantly increased both NO and MCP-1 secretion from Kupffer cells.
- L-NAME inhibited NO production but did not affect MCP-1 levels.
- Wortmannin inhibited both NO and MCP-1 production, indicating PI3-kinase involvement.
- A positive correlation was observed between NO and MCP-1 with LPS and Wortmannin, but not L-NAME.
- Exogenous MCP-1 did not enhance NO production.
Conclusions:
- Kupffer cells are a significant source of NO and MCP-1 in liver disorders.
- NO and MCP-1 production by KC are likely regulated by independent pathways, possibly involving PI3-kinase.
- These findings suggest distinct immunoregulatory roles for NO and MCP-1 in hepatic disease pathogenesis.

